Construct Validity of a New Migraine Satisfaction with Treatment Questionnaire

Speaker(s)

Ruiz MA1, Moya MC2, Soto J3, Rejas J1, Gago-Veiga A4, González-García N5, Díaz de Terán J6, Heredia-Rodríguez P4, Camiña J7, García-Azorín D8, Giné-Ciprés E9, González-Quintanilla V10, Torres-Ferrús M9, Armada B3
1Universidad Autónoma de Madrid, Madrid, Madrid, Spain, 2Pfizer Spain, Alcobendas, Madrid, Spain, 3Pfizer Spain, Madrid, Madrid, Spain, 4University Hospital La Princesa, Madrid, Madrid, Spain, 5Hospital Clínico San Carlos, Madrid, Madrid, Spain, 6University Hospital La Paz, Madrid, Madrid, Spain, 7University Hospital Son Espases, Baleares, Baleares, Spain, 8Hospital Clínico Universitario de Valladolid, Valladolid, Spain, 9University Hospital Vall d'Hebron, Barcelona, Cataluña, Spain, 10University Hospital Marqués de Valdecilla, Santander, Cantabria, Spain

Presentation Documents

OBJECTIVES: The aim of this study is to test the content validity of a new questionnaire measuring satisfaction with Treatment in migraine patients, the MISSAT-Q.

METHODS: After thorough scientific literature review and grounded in the SATMED-Q satisfaction model, a total of 35 items were produced to build up the questionnaire. Eight dimensions were defined to structure the questionnaire: Treatment effectiveness in crisis and in prevention, side effects, convenience, impact on Health-Related-Quality-of-Life (HRQoL), monitoring, emotions, and overall satisfaction. An expert panel composed by 3 clinicians, 1 nurse, 3 pharma-economists, 1 expert patient and 1 methodologist supervised item generating process. Thirteen content-specialists in migraine (8 clinicians, 2 nurses, 2 health-outcomes-research specialists and 1 psychologist) valued each of the proposed items in all 8 dimensions defined by the questionnaire (1=measured, 0=unsure, -1=not measured). Item-Domain congruence was measured using the Hambleton-Rovinelli (1976) procedure for assessing item validity by inter-rater agreement.

RESULTS: All items obtained a positive score in the theoretical intended dimension, ranging between 0.52 and 0.92 (88%≥0.70). Most items obtained lower and negative scores in all other dimension. The following pattern was observed: The overall satisfaction dimension tended to obtain low positive scores for most items. Similarly, HRQoL dimension tended to obtain moderate positive scores on most items, particularly for side-effect, prevention and emotion items.

Content-specialists agreed on the assignment of items to their construct dimension as the main measurement dimension. Albeit two dimensions gathered some minor positive values from other theoretic dimension: overall satisfaction, prevention and emotions. This result was expected since the treatment satisfaction construct assumes dimensions to be conceptually correlated.

CONCLUSIONS: Results from the item-Domain congruence task evidence on the validity of most items proposed to measure the Migraine Treatment Satisfaction concept structure, pointing out particular items which may be problematic in further validation steps, like confirmatory factor analysis.

Code

PCR12

Topic

Clinical Outcomes, Methodological & Statistical Research, Patient-Centered Research

Topic Subcategory

Instrument Development, Validation, & Translation, Performance-based Outcomes, PRO & Related Methods, Stated Preference & Patient Satisfaction

Disease

Neurological Disorders